Codexis (CDXS) FCF Margin (2010 - 2026)

Codexis' (CDXS) quarterly FCF Margin came in at 90.2% in Q1 2026, up 10936.0% year-on-year from N/an in Q1 2025, and down 321.7% quarter-over-quarter from 40.69% in Q4 2025.

Codexis (CDXS) FCF Margin (2010 - 2026) Analysis & Trends

Codexis' FCF Margin history runs 17 years deep, the most recent figure standing at 90.2% for Q1 2026.

  • On a quarterly basis, FCF Margin rose 10936.0% year-over-year to 90.2% in Q1 2026; TTM through Mar 2026 was 28.87%, a 9127.0% increase from a year earlier, with the FY2025 full-year figure at 33.88%, up 5663.0% from the prior year.
  • FCF Margin retreated to 90.2% in Q1 2026 per CDXS's latest filing, from 40.69% in the prior quarter.
  • Across five years, FCF Margin topped out at 62.42% in Q4 2022 and bottomed at 353.36% in Q2 2023.
  • The 5-year median for FCF Margin is 91.24% (2024), against an average of 98.25%.
  • Across the five-year window, FCF Margin sank 36834 bps in 2023 and surged 21028 bps in 2024, its largest moves.
  • Year by year, FCF Margin stood at 62.42% in 2022, then tumbled by 590 bps to 305.92% in 2023, then soared by 69 bps to 95.64% in 2024, then surged by 143 bps to 40.69% in 2025, then plunged by 322 bps to 90.2% in 2026.
  • Per Business Quant, the three latest CDXS FCF Margin figures stand at 90.2% (Q1 2026), 40.69% (Q4 2025), and 91.47% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 10.45%
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 23.53%
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Codexis 135.70 Mn 70.56 Mn 13.18 Mn -90.20%

Historic Data

Download Data
DateValue
Mar 31, 2026 -90.20%
Dec 31, 2025 40.69%
Sep 30, 2025 -91.47%
Jun 30, 2025 -109.34%
Mar 31, 2025 -199.56%
Dec 31, 2024 -95.64%
Sep 30, 2024 -91.24%
Jun 30, 2024 -157.45%
Mar 31, 2024 -52.24%
Dec 31, 2023 -305.92%
Sep 30, 2023 -133.03%
Jun 30, 2023 -353.36%
Mar 31, 2023 -90.52%
Dec 31, 2022 62.42%
Sep 30, 2022 53.45%
Jun 30, 2022 -10.73%
Mar 31, 2022 -46.05%
Dec 31, 2021 -19.67%
Sep 30, 2021 -22.31%
Jun 30, 2021 -31.64%